AdipoPharma

Strasbourg, France · Founded 2017 · Privately Held (backing)

Developer of a peptide-based drug designed to offer treatment for patients suffering from type 2 diabetes. AdipoPharma is based in Strasbourg, France and was founded in 2017. Its last known valuation is $18.4 million. It has raised $34.5 million.

Last price · $/share
—
Implied valuation
$18.4M
Total raised
$34.5M
Last round
—

Who backs AdipoPharma?

11 investors
InvestorType
BpifranceOther
Morningside GroupVenture capital
Good Growth CapitalVenture capital
Okeanos (United States)Venture capital
SambrInvestOther
Capital Grand EstPE / buyout
Conectus—
Investsud—
Ministère de l'Education nationale—
Newton BioCapital—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

AdipoPharma investors

11 investors are on record for AdipoPharma, including Bpifrance, Morningside Group, Good Growth Capital and Okeanos (United States).

Free account
More of AdipoPharma with a free account
  • ·The complete investor list: 11 names
  • ·Watch AdipoPharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like AdipoPharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View